Tower Research Capital LLC (Trc) Aspira Women'S Health Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.32 - $0.58 $6,830 - $12,379	21,344 Added 56168.42%	21,382 $8,000
Q4 2022 Feb 10, 2023	SELL	$0.3 - $0.41 $7,468 - $10,206	-24,894 Reduced 99.85%	38 $0
Q3 2022 Nov 10, 2022	BUY	$0.38 - $1.07 $8,071 - $22,726	21,240 Added 575.3%	24,932 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $13,316 - $36,287	-33,291 Reduced 90.02%	3,692 $2,000
Q1 2022 May 12, 2022	SELL	$0.88 - $1.81 $5,581 - $11,480	-6,343 Reduced 14.64%	36,983 $38,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $59,434 - $125,068	36,463 Added 531.3%	43,326 $77,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $3,843 - $6,603	1,205 Added 21.3%	6,863 $22,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $6.84 $2,542 - $3,638	-532 Reduced 8.59%	5,658 $31,000
Q1 2021 May 17, 2021	SELL	$5.9 - $9.13 $525 - $812	-89 Reduced 1.42%	6,190 $42,000
Q4 2020 Feb 16, 2021	SELL	$3.0 - $6.71 $136,056 - $304,311	-45,352 Reduced 87.84%	6,279 $42,000
Q3 2020 Nov 16, 2020	BUY	$2.54 - $4.56 $119,377 - $214,315	46,999 Added 1014.66%	51,631 $159,000
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.25 $3,612 - $24,318	4,632 New	4,632 $18,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.